Microfluidic Leukocyte Stretching for High-Throughput Deformability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for measuring cell deformability suffer from low throughput and inconsistent results, requiring costly reagents and skilled operators, which limits their clinical impact and ability to detect rare cellular events or variations.
Innovation Solution
A microfluidic device utilizing intersecting flows to create an extensional region for controlled cell stretching, combined with high-speed imaging and automated analysis, enabling the measurement of cellular mechanical parameters at over 1,000 cells per second.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If single-cell platforms (AFM, optical stretching) are used to measure cell deformability, then measurement precision is improved, but productivity deteriorates to around 1 cell/minute
Solution Approach 1:
The invention segments the measurement process by using parallel microfluidic channels to simultaneously measure multiple cells. Instead of measuring one cell at a time with AFM or optical stretching, the system divides the sample into many individual measurement streams, achieving high throughput while maintaining single-cell measurement precision through parallel processing architecture
Solution Approach 2:
The invention uses microfluidic hydraulic flows to replace the mechanical contact of AFM and the complex optical systems of optical stretching. By using controlled fluid flows through microchannels, the system achieves cell deformation and measurement with simpler, more scalable hardware that can operate at high speeds while maintaining measurement accuracy
2Productivity
If bulk platforms (microfiltration) are used to measure cell deformability, then productivity is improved with high throughput, but measurement precision deteriorates by yielding only one endpoint measurement that does not account for heterogeneity
Solution Approach 1:
The invention segments the bulk sample into individual cell measurements using parallel microfluidic channels. Each channel provides an independent measurement stream, allowing the system to process large numbers of cells while maintaining the ability to detect rare events and local variations within the population, thus combining high throughput with precise heterogeneity detection
Solution Approach 2:
The invention transitions from single-endpoint bulk measurement to multi-dimensional single-cell measurements by using arrays of parallel microfluidic channels. This dimensional expansion allows simultaneous measurement of many cells across multiple parameters, providing both high throughput and detailed information about cellular heterogeneity
3Measurement precision
If costly reagents and skilled technicians are used for current cell deformability measurements, then measurement precision is improved, but device complexity and operational difficulty increase
Solution Approach 1:
The invention enables self-service operation by using passive microfluidic flows and automated imaging systems that do not require skilled manual intervention. The system automatically focuses cells, applies deformation, captures images, and analyzes data, eliminating the need for skilled operators while maintaining measurement precision through standardized automated protocols
Solution Approach 2:
The invention replaces complex mechanical systems like AFM with microfluidic hydraulic systems. This substitution simplifies the device architecture by using flow-based deformation instead of mechanical contact, reducing the need for precision mechanical components and skilled operators while maintaining measurement capability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system provides high-throughput, label-free cell deformability measurements, reducing costs and labor, and enabling accurate detection of cellular heterogeneity for clinical diagnostics and drug screening.
Implementation Method 1
The microfluidic device uses intersecting flows to create an extensional flow region where the cells undergo controlled stretching
Implementation Method 2
Each cell's deformation is measured with an imaging device
Data Source
AI summary
A system is disclosed that enables the automated measurement of cellular mechanical parameters at high throughputs. The microfluidic device uses intersecting flows to create an extensional flow region where the cells undergo controlled stretching. Cells are focused into streamlines prior to entering the extensional flow region. In the extensional region, each cell's deformation is measured with an imaging device. Automated image analysis extracts a range of independent biomechanical parameters from the images. These may include cell size, deformability, and circularity. The single cell data that is obtained may then be used to in a variety of ways. Scatter density plots of deformability and circularity may be developed and displayed for the user. Mechanical parameters such as deformability and circularity may be gated or thresholded to identify certain cells of interest or sub-populations of interest. Similarly, the mechanical data obtained using the device may be used as cell signatures.